US2023078265A1PendingUtilityA1

Methods and compositions for editing nucleotide sequences

Assignee: BROAD INST INCPriority: Mar 19, 2019Filed: Mar 19, 2020Published: Mar 16, 2023
Est. expiryMar 19, 2039(~12.6 yrs left)· nominal 20-yr term from priority
C12N 15/90C12N 15/111C12N 2310/3515C12Y 207/07049C12N 15/62C07K 2319/00G16B 25/20A61P 25/14C12N 2310/20C12N 15/102C12N 9/22G16B 20/00C12N 2310/3519C07K 2319/92C12N 9/1276A61P 9/00C07K 2319/80C07K 14/001C12Y 301/00A61P 9/12C12N 15/902A61K 38/465A61P 3/04A61P 17/00A61P 25/28C12N 15/1089A61K 48/005C12N 15/113A61K 38/45A61P 37/02A61P 7/06A61P 43/00C12N 15/79C12N 15/11C12N 15/907A61P 19/02C12N 2800/80A61P 35/00C12N 2310/3517A61P 3/10
74
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure provides compositions and methods for conducting prime editing of a target DNA molecule (e.g., a genome) that enables the incorporation of a nucleotide change and/or targeted mutagenesis. The nucleotide change can include a single-nucleotide change (e.g., any transition or any transversion), an insertion of one or more nucleotides, or a deletion of one or more nucleotides. More in particular, the disclosure provides fusion proteins comprising nucleic acid programmable DNA binding proteins (napDNAbp) and a polymerase (e.g., reverse transcriptase), which is guided to a specific DNA sequence by a modified guide RNA, named an PEgRNA. The PEgRNA has been altered (relative to a standard guide RNA) to comprise an extended portion that provides a DNA synthesis template sequence which encodes a single strand DNA flap, which is homologous to a strand of the targeted endogenous DNA sequence to be edited, but which contains the desired one or more nucleotide changes and which, following synthesis by the polymerase (e.g., reverse transcriptase), becomes incorporated into the target DNA molecule. Also disclosed herein are various methods that leverage prime editing, including treating trinucleotide repeat contraction diseases, installing targeted peptide tags, treating prion disease through the installation of protection mutations, manipulating RNA-encoding genes for the installation of RNA tags for controlling the function and expression of RNA, using prime editing to construct sophisticated gene libraries, using prime editing to insert immunoepitopes into proteins, use of prime editing to insert inducible dimerization domains into protein targets, and delivery methods, among others.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of installing a ribonucleotide motif or tag in an RNA of interest encoded by a target nucleotide sequence by prime editing, the method comprising: (a) contacting the target nucleotide sequence with a (i) prime editor comprising a nucleic acid programmable DNA binding protein (napDNAbp) and a polymerase, and (ii) a PEgRNA comprising an edit template encoding the ribonucleotide motif or tag; thereby polymerizing a single strand DNA sequence encoding the ribonucleotide motif or tag; and incorporating the single strand DNA sequence in place of a corresponding endogenous strand at the target nucleotide sequence through a DNA repair and/or replication process, wherein the method produces a target nucleotide sequence that encodes a modified RNA of interest comprising the ribonucleotide motif or tag. 
     
     
         2 . The method of  claim 1 , wherein ribonucleotide motif or tag is a detection moiety. 
     
     
         3 . The method of  claim 1 , wherein the ribonucleotide motif or tag affects the expression level of the RNA of interest. 
     
     
         4 . The method of  claim 1 , wherein the ribonucleotide motif or tag affects the transport or subcellular location of the RNA of interest. 
     
     
         5 . The method of  claim 1 , wherein the ribonucleotide motif or tag is selected from the group consisting of SV40 type 1, SV40 type 2, SV40 type 3, hGH, BGH, rbGlob, TK, MALAT1 ENE-mascRNA, KSHV PAN ENE, Smbox/U1 snRNA box, U1 snRNA 3′ box, tRNA-lysine, broccoli aptamer, spinach aptamer, mango aptamer, HDV ribozyme, and m6A. 
     
     
         6 . The method of  claim 1 , wherein the PEgRNA comprises SEQ ID NOs: 101-104, 181-183, 223-244, 277, 325-334, 336, 338, 340, 342, 344, 346, 348, 350, 352, 354, 356, 358, 360, 362, 364, 366, 368, 499-505, 735-761, 776-777 (see Table). 
     
     
         7 . The method of  claim 1 , wherein the fusion protein comprises the amino acid sequence of PE1, PE2, or PE3. 
     
     
         8 . The method of  claim 1 , wherein the napDNAbp is a Cas9 nickase (nCas9). 
     
     
         9 . The method of  claim 1 , wherein the napDNAbp comprises the amino acid sequence of SEQ ID NOs: 18-88, 126, 130, 137, 141, 147, 153, 157, 445, 460, 467, and 482-487.

Join the waitlist — get patent alerts

Track US2023078265A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.